A Study of RAY1225 in Participants With Type 2 Diabetes

Clinical trial NCT06254274 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06254274
Sponsor: Guangdong Raynovent Biotech Co., Ltd
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

T2DM (Type 2 Diabetes Mellitus)

Start date: 2024-02-26
Primary completion: 2025-12-20
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.